Results 131 to 140 of about 4,576,038 (327)

Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy

open access: yesAIDS (London), 2014
Objective:The objective of this study is to estimate life expectancies of HIV-positive patients conditional on response to antiretroviral therapy (ART).
M. May   +21 more
semanticscholar   +1 more source

Free antiretrovirals as a key tool against the HIV pandemic: A systematic review

open access: yesHIV Medicine, EarlyView.
Abstract Background/Objectives Access to antiretroviral (ARV) drugs remains a critical challenge in achieving the WHO/UNAIDS 95‐95‐95 targets, with medication costs representing a substantial barrier. This systematic review evaluates the effect of free ARVs, without out‐of‐pocket cost to the patient, on the HIV cascade of care: the use of ARV therapy ...
Melissa Doutre   +6 more
wiley   +1 more source

A One-Year Prospective Developmental Assessment of HIV-Positive Infants and Children on Triple Antiretroviral Therapies [PDF]

open access: bronze, 1999
Enrique Gular   +5 more
openalex   +1 more source

Patient‐reported outcomes in clinical trials assessing the effectiveness of cabotegravir + rilpivirine long‐acting injections as antiretroviral therapy: A systematic review

open access: yesHIV Medicine, EarlyView.
Abstract Introduction: Human immunodeficiency virus‐1 (HIV‐1) continues to have a high global burden, with approximately 39.9 million people currently living with the virus. Despite the clinical success of antiretroviral therapy (ART), adherence remains a significant challenge, often due to emotional distress and HIV‐related stigma.
Dhruv Vinay   +3 more
wiley   +1 more source

Retention outcomes during same‐day antiretroviral therapy initiation in health facilities and outreach settings of Rakai, Uganda, 2016–2021

open access: yesHIV Medicine, EarlyView.
Abstract Introduction The antiretroviral therapy (ART) initiation policy in Uganda recommends that ART is initiated on the same day of HIV diagnosis to those who do not have contraindications. We assessed determinants of retention in ART care at the first follow‐up (FFU) after same‐day ART initiation and retention in long‐term care beyond the FFU visit.
Jesca Basiima   +15 more
wiley   +1 more source

Rapid start with bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) as initial treatment in people with human immunodeficiency virus‐1 (HIV‐1): A systematic literature review of clinical and patient‐reported outcomes

open access: yesHIV Medicine, EarlyView.
Abstract Background Treatment guidelines recommend rapid antiretroviral therapy (ART) initiation among eligible people with HIV to improve treatment outcomes and reduce HIV transmission. Bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF), an integrase strand transfer inhibitor‐based single‐tablet regimen, is recommended for rapid start in US and
Jade Ghosn   +11 more
wiley   +1 more source

Persistence of HIV-1 Transcription in Peripheral-Blood Mononuclear Cells in Patients Receiving Potent Antiretroviral Therapy [PDF]

open access: bronze, 1999
Manohar R. Furtado   +7 more
openalex   +1 more source

Mode of administration matters: Willingness of people with HIV to switch to future long‐acting treatments, and health care professionals' intention to discuss these options

open access: yesHIV Medicine, EarlyView.
Abstract Introduction Understanding preferences for long‐acting regimens (LAR) of people with HIV and health care professionals (HCPs) is important to optimize and personalize care. We identified preferences for current and future LAR among people with HIV and investigated HCPs’ willingness to discuss these options.
Kyra F. Mendes de Leon   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy